omniture

China Cord Blood Corporation to Announce Fourth Quarter and Fiscal Year 2010 Financial Results

2010-06-17 13:10 1972

Earnings Call Scheduled for June 22, 2010

HONG KONG, June 16 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO; "the Company") today announced its plan to release financial results for the fourth quarter and fiscal year 2010 on Tuesday, June 22, 2010, before the market open in the US.

The Company will hold a teleconference at 8:00 a.m. ET on Tuesday, June 22, 2010 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session. Interested parties may access the audio webcast through the following link: http://phx.corporate-ir.net/playerlink.zhtml?c=206671&s=wm&e=3126984. A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above. Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 79227376.

Supplemental financial information referenced in the conference call and the text of the fourth quarter and annual results press release can be found at http://www.chinacordbloodcorp.com, in the section titled Investor Center/Press Release, after 7:00 a.m. ET on the morning of the conference call.

Please dial in ten minutes prior to the conference to ensure proper connection. Please be prepared to provide your name and company to the operator.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with access to more than one license (i.e., Beijing, Guangdong and Shandong). Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses have been issued as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.

For more information, please contact:

China Cord Blood Corporation

Ms. Joeling Law

Tel: +852-3605-8180

Email: joeling.law@chinacordbloodcorp.com

Integrated Corporate Relations, Inc.

In New York: Ashley M. Ammon or Christine Duan: 1-646-277-1227

In Beijing: Wei-Jung Yang: +86-10-6599-7968

Source: China Cord Blood Corporation
Related Stocks:
NYSE:CO
collection